[PR of clinical testing].
Regardless of its vital role of providing quality of patients care and optimizing overall healthcare costs, a clinical testing in Japan bears too strong cost containment pressures, which lead to too economically driven cost reduction initiatives. As a result, there is a risk of hampering infrastructure of appropriate medical services in Japan, including accuracy of tests, speed of tests, adoptation of new IVD technology, quality of information, adding value information, risk management, etc. In order to maintain a proper clinical testing in Japan, people/organizations associated with IVD and clinical testing should take more proactive PR actions to appeal the importance and value addition of clinical testing to patients, media, governments, hospital management, and other medical professionals.